The 11th Bioproduction Congress (BioPC2026) brings together experts from pharmaceutical companies, biotech, start-ups, research institutions and technology providers to explore the latest developments in bioprocessing and biomanufacturing. Taking place on 22 & 23 September 2026 in Lyon, France, the congress focuses on advancing biotherapeutics from development towards robust and scalable commercial manufacturing. The program covers topics including next-generation biotherapies, analytical methods, process control, automation, quality systems, smart manufacturing and regulatory perspectives. Expert presentations, workshops, panel discussions and B2B meetings provide opportunities to exchange practical insights and explore new approaches to current challenges in bioproduction. A particular focus in 2026 is on biotherapeutics developability and risk mitigation, highlighting innovative strategies for improving efficiency, quality and manufacturing readiness. wega will participate in the event to connect with industry professionals and exchange perspectives on digitalization, automation and data-driven approaches for modern biomanufacturing.

Further details about the event can be found here.